TEMPO Ultra WP Insecticide

SECTION 2: Hazards identification

EMERGENCY OVERVIEW * CAUTION! Color Tan; Form Powder; Odor Slightly * * aromatic; Harmful if inhaled; Harmful if absorbed through * * skin; Causes eye irritation; Harmful if swallowed. * *****************************************************************

Principle Routes of Exposure

Inhalation; Skin Contact; Skin Absorption; Eye Contact HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE: ACUTE EFFECTS OF EXPOSURE.....: Skin and mucous membrane irritation may occur from contact with the product and produce symptoms such as itching, stinging, skin reddening or rash. Paresthesia (a tingling or burning sensation on the surface of the skin) may also result from skin contact. These are frequently reported symptoms associated with sufficient dermal exposure to alpha-cyano (Type II) synthetic pyrethroids and normally subside without treatment within 24 hours. The onset of these symptoms usually occurs 2-12 hours after exposure. The effects are temporary and are reversible. Based on the EPA Toxicity Category criteria, this material is mildly toxic by the oral and dermal routes of exposure. In addition, animal studies have shown that it can cause mild irritation to the conjunctiva of the eye with all irritation resolving within 7 days.

Potential chronic health

OF EXPOSURE... Based on animal studies, no adverse effects or symptoms would be expected from chronic exposure to the active ingredient in this product during normal use. This product may contain an amount of total crystalline silica which ranges from less than 1% to approximately 7%. However, the amount of respirable crystalline silica is expected to be significantly lower based on data provided by the raw material manufacturer. Excessive long-term exposure to respirable crystalline silica may cause silicosis, a form of progressive pulmonary fibrosis. Severe and permanent lung damage may result. CARCINOGENICITY...............: This product is not listed as a carcinogen by NTP or IARC, or regulated as a carcinogen by OSHA. However, it may contain crystalline silica (quartz), a substance which is classified by NTP as a Group 2 carcinogen and by IARC as a Group I carcinogen. Crystalline silica is a naturally-occurring mineral component of many sands and clays. Although controversial, the carcinogenic potential of crystalline silica must be considered if it is inhaled under excessive exposure conditions. However, the respirable portion of the silica which may be contained in this product is small, such that excessive inhalation exposure during normal conditions of use is unlikely. NTP.........................: Crystalline silica is classified as an NTP Anticipated Human Carcinogen - "Substances or groups of substances that may reasonably be anticipated to be carcinogens." IARC........................: IARC has classified crystalline silica as a Group 1 carcinogen. "There is sufficient evidence in humans for the carcinogenicity of inhaled crystalline silica (quartz) from occupational sources." OSHA........................: Not regulated MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE......: No specific medical conditions are known which may be aggravated by exposure to the active ingredient in this product. As with all materials which can cause upper respiratory tract irritation, persons with a history of asthma, emphysema, or hyperreactive airways disease may be more susceptible to a response at low concentration. In addition, pulmonary and respiratory diseases may be aggravated by exposure to respirable crystalline silica. -------------------------------------------------------------------------------